Alan Smith, Ph.D.
Dr. Smith brings over 30 years of executive industry management in research and development, operations, manufacturing and quality roles to Armis Biopharma®. He has served on our Board of Directors since it was formed in 1998. He joined Bellicum Pharmaceuticals Inc. (NASDAQ: BLCM), his current employer, in 2015 as Sr. Vice President, Manufacturing and currently serves as Executive Vice President of Technical Operations. Prior to this, he served as the Vice President of Research & Development and Cellular Therapeutics for LifeNet Health and its subsidiary, The Institute of Regenerative Medicine (2013-2015). Previously, Dr. Smith owned an independent consulting business in the cell therapy industry (2010-2013).
Before this he served as President and Chief Executive Officer and in other executive roles for Cognate BioServices (2002-2010); as Chief Operating Officer and Sr. Vice President of Research and Development at Osiris Therapeutics (NYSE: OSIR); as Vice President of Research and Development at Aastrom Biosciences; as Vice President of Research and Development Geneic Sciences at Baxter Healthcare Corporation (now Baxter International Inc., NYSE: BAX); and several other leadership positions in additional companies.
Dr. Smith is a published co-author on numerous journal articles and recently served as an Adjunct Professor at Eastern Virginia Medical School, Department of Biology and Molecular Cell Biology.
His past academic experience includes adjunct professorships at California State University Long Beach and Utah, State University. Dr. Smith earned his BS degree in Chemistry at Southern Utah University in 1976 and a PhD degree in Biochemistry from Utah State University in 1982.